Form 4: Dolby Labs Exec Reports Significant Equity Transactions

Dolby Laboratories' EVP, General Counsel & Secretary, Mark Andrew Sherman, reported multiple equity transactions including RSU grants, PSU vesting, option grants, and stock sales.

Summary

• Mark Andrew Sherman, EVP, General Counsel & Secretary of Dolby Laboratories, Inc. (DLB), reported several equity transactions between December 15 and December 17, 2025.
• On December 15, 2025, Sherman was granted 25,633 restricted stock units (RSUs) under the Issuer's 2020 Stock Plan, vesting 1/4 annually starting December 15, 2025.
• Also on December 15, 2025, 5,915 performance-based restricted stock units (PSUs) from a 2022 grant vested, following the Compensation Committee's certification of 64.65% achievement of target performance criteria.
• A new grant of 12,816 performance-based restricted stock units (PSUs) was awarded on December 15, 2025, with vesting contingent on performance criteria (annualized total shareholder return compared to the S&P Mid Cap 400 Index) over a three-year period (December 15, 2025, to December 12, 2028) and service-based vesting.
• Sherman also received a grant of 56,440 employee stock options on December 15, 2025, with an exercise price of $66.62, vesting 1/4 on December 15, 2025, and monthly thereafter over 36 months, expiring December 15, 2035.
• To cover withholding taxes incidental to the vesting of restricted stock units, Sherman disposed of 9,252 shares at $67.54 on December 15, 2025, and 2,530 shares at $66.62 on December 16, 2025.
• Sherman sold a total of 11,600 shares of Class A Common Stock through multiple transactions on December 16 and 17, 2025, pursuant to a 10b5-1 trading plan adopted on February 28, 2025.
• The sales included 6,738 shares at a weighted average price of $66.5758, 2,371 shares at $67.1705, and 2,491 shares at $67.2637.
• Following these transactions, Sherman's direct beneficial ownership of Class A Common Stock, including unvested RSUs, was 70,563 shares.

Sentiment

Score: 5

Explanation: The filing is a routine Form 4 reporting insider transactions related to executive compensation and pre-planned stock sales. It does not contain information that would significantly alter the company's fundamental outlook or immediate share price, thus maintaining a neutral sentiment.

Positives

• Mark Andrew Sherman received significant new equity awards, including 25,633 restricted stock units and a target of 12,816 performance-based restricted stock units, aligning his interests with long-term shareholder value.
• The vesting of 5,915 performance-based restricted stock units from a prior grant indicates the company's Compensation Committee certified the achievement of performance criteria at 64.65% of the target award.
• The grant of 56,440 employee stock options provides a long-term incentive for the executive, with an exercise price of $66.62.

Negatives

• Mark Andrew Sherman sold a total of 11,600 shares of Class A Common Stock over two days, which could be perceived as a reduction in his direct equity exposure, although these sales were pre-planned under a 10b5-1 plan.

Risks

• The vesting of the new 12,816 performance-based restricted stock units is dependent on the achievement of performance criteria (annualized total shareholder return compared to the S&P Mid Cap 400 Index) over a three-year period, meaning the actual number of shares received could range from 0% to 200% of the target award.
• Shares underlying restricted stock units are subject to forfeiture until they vest, posing a risk to the executive's full realization of the awarded equity.

Future Outlook

The executive's future compensation is tied to long-term performance through new RSU and PSU grants with multi-year vesting schedules. The new performance-based restricted stock units have a three-year performance period ending December 12, 2028, with potential payouts ranging from 0% to 200% of the target award based on total shareholder return relative to the S&P Mid Cap 400 Index. Employee stock options have an expiration date of December 15, 2035, providing a long-term incentive horizon.

Management Comments

• The Issuer's Compensation Committee certified the achievement of performance criteria for the 2022 performance-based restricted stock unit award at 64.65% of the target amount, resulting in the vesting of 5,915 PSUs.

Industry Context

This Form 4 filing reflects routine executive compensation practices within the technology and entertainment industry, where equity awards like RSUs, PSUs, and stock options are common tools for attracting, retaining, and incentivizing key management personnel. The use of a 10b5-1 trading plan for stock sales is a standard practice for insiders to sell shares in a pre-arranged, compliant manner, mitigating concerns about trading on material non-public information.

Comparison to Industry Standards

• The use of restricted stock units (RSUs) and performance-based restricted stock units (PSUs) as a significant component of executive compensation is a common practice across publicly traded companies, particularly in the technology sector, aligning executive incentives with long-term shareholder value.
• The structure of PSU awards, tying vesting to relative total shareholder return (TSR) against an index like the S&P Mid Cap 400, is a widely adopted performance metric in executive compensation plans to ensure competitive performance.
• The adoption of a Rule 10b5-1 trading plan for stock sales is a standard corporate governance practice for executives to manage their personal stock holdings in a pre-scheduled and transparent manner, similar to plans used by executives at companies like Apple, Microsoft, and Google.

Corporate Governance

Stakeholder Impact

• Shareholders: The filing details routine executive compensation and pre-planned stock sales, which are generally expected and do not indicate a significant shift in company strategy or performance. The equity awards align executive interests with long-term shareholder value.
• Employees: The equity grants are part of the company's compensation structure, which can influence employee morale and retention, particularly for key executives.

Next Steps

• The granted restricted stock units will vest in 1/4 increments annually, starting December 15, 2025.
• The newly granted performance-based restricted stock units will vest upon the later of three years from the grant date and certification by the Compensation Committee of performance criteria achievement, following the end of the three-year performance period on December 12, 2028.
• The employee stock options will vest 1/4 on December 15, 2025, with the balance vesting in equal monthly installments over the subsequent 36 months.

Key Dates

Keywords

Dolby Laboratories, DLB, Form 4, Insider Trading, Restricted Stock Units, Performance-Based Restricted Stock Units, Employee Stock Options, Executive Compensation, Stock Sales, 10b5-1 Plan